Latest Federal Court News

Little Green Pharma has secured Federal Court approval for its full acquisition of Cannatrek, marking a key milestone in expanding its global medicinal cannabis footprint. The scheme became effective on 25 May 2026, with implementation set for 1 June.

Solvar Limited has renewed its on-market share buy-back for 12 months, signalling ongoing capital management amid evolving market conditions.

Equity Trustees Superannuation Limited (ETSL) will contest ASIC's Federal Court civil proceedings related to the First Guardian Master Fund, where member losses total around $70 million. The trustee insists it acted within its fiduciary duties amid ongoing liquidation efforts.

The Australian Taxation Office has issued a Class Ruling confirming scrip for scrip capital gains tax roll-over relief for Diversified United Investment shareholders following their merger with Australian United Investment Company.

Australian Strategic Materials Limited (ASM) shareholders are set to vote on a scheme of arrangement for Energy Fuels Inc. to acquire 100% of ASM shares and options, offering a significant premium and exposure to a vertically integrated rare earth supply chain.

Sequoia Financial Group has pushed back its interim dividend payment to 3 June 2026, citing ongoing Federal Court proceedings triggered by ASIC over the contested sale of its InterPrac subsidiary.

Titomic Limited is set to shift its corporate domicile from Australia to the United States through a scheme of arrangement, aiming to deepen its US defense market presence and access broader capital pools while maintaining its ASX listing.

Amaero Ltd has sent out its Scheme Booklet for the upcoming June 5, 2026 meetings where shareholders will vote on the company’s re-domiciliation to the US and approve new incentive options.

Toro Energy has sent its Scheme Booklet to shareholders outlining the proposed takeover by IsoEnergy, backed by an independent expert and the company’s board. Key dates for shareholder voting and court approval are set for June.

Amaero Ltd is set to re-domicile from Australia to Delaware via court-approved schemes, issuing US HoldCo CHESS Depositary Interests to shareholders while maintaining its ASX listing. The move aims to tap into deeper US capital markets and enhance strategic growth opportunities.

Little Green Pharma (ASX:LGP) posted record quarterly and annual revenues driven by a surge in European sales, improved cashflow, and reduced debt. The company is on track to complete its merger with Cannatrek by June 1, 2026, while benefiting from the US rescheduling of medicinal cannabis to Schedule III.

Titomic Limited is gearing up for a strategic shift to the US with a planned redomicile in H2 2026, while clinching major contracts across aerospace, defense, and rail sectors and achieving critical certifications that underpin its manufacturing ambitions.